Metraipolis › archive › dc_cf2fd6020e48
DUX4 reduction and muscle function improvement by subcutaneous delivery of gapmer antisense oligonucleotides — Europe PMC PMID:41536811
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41536811
- DOI
- 10.1016/j.omtn.2025.102791
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T19:17:33.190Z
- SHA-256 of the archived text
9e9fb4e19654722a5bda015d0166bcdd8813724e493ff2ca8f52f2bafe3f3ea2- Stable URL of this page
https://metraipolis.com/documento/dc_cf2fd6020e48
How to cite
DUX4 reduction and muscle function improvement by subcutaneous delivery of gapmer antisense oligonucleotides — Europe PMC PMID:41536811 — Europe PMC (en), https://europepmc.org/article/MED/41536811 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf2fd6020e48 (Metraipolis archive dc_cf2fd6020e48, sha256 9e9fb4e19654722a5bda015d0166bcdd8813724e493ff2ca8f52f2bafe3f3ea2)
BibTeX
@misc{dccf2fd6020e48,
title = {DUX4 reduction and muscle function improvement by subcutaneous delivery of gapmer antisense oligonucleotides — Europe PMC PMID:41536811},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41536811},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf2fd6020e48; sha256 9e9fb4e19654722a5bda015d0166bcdd8813724e493ff2ca8f52f2bafe3f3ea2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41536811. Agents can read the archived copy with the MCP tool read_document.